Le. Matarese et al., Foscarnet-induced electrolyte abnormalities in a bone marrow transplant patient receiving parenteral nutrition, J PARENT EN, 24(3), 2000, pp. 170-173
Cytomegalovirus (CMV) is a serious complication of immunosuppressed patient
s receiving bone marrow transplantation. Foscarnet, a pyrophosphate analog,
has been used in the treatment of CMV infections. Renal impairment and ele
ctrolyte abnormalities are potential adverse reactions associated with the
use of foscarnet. We report a case of significant electrolyte changes after
initiation of foscarnet in a bone marrow transplant patient recieving pare
nteral nutrition.